CLINICAL_TRIALS
trial_result
· 2014-01-13
Clinical Trial Update: Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis [Phase 2]
Summary
Phase 2 trial assessing efficacy, safety and tolerability of denosumab in rheumatoid arthritis has completed with posted results in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2014-01-13